Twelve Reasons for Considering Buprenorphine as a Frontline Analgesic in the Management of Pain
- 1 November 2012
- journal article
- review article
- Published by Elsevier in The Journal of Supportive Oncology
- Vol. 10 (6), 209-219
- https://doi.org/10.1016/j.suponc.2012.05.002
Abstract
No abstract availableKeywords
This publication has 188 references indexed in Scilit:
- Pronociceptive Pain Modulation in Patients with Painful Chemotherapy-Induced PolyneuropathyJournal of Pain and Symptom Management, 2011
- Differential Pharmacological Actions of Methadone and Buprenorphine in Human Embryonic Kidney 293 Cells Coexpressing Human μ-Opioid and Opioid Receptor-Like 1 ReceptorsNeurochemical Research, 2011
- Errors in Opioid Prescribing: A Prospective Survey in Cancer PainJournal of Pain and Symptom Management, 2010
- Characteristics and comparative severity of respiratory response to toxic doses of fentanyl, methadone, morphine, and buprenorphine in ratsToxicology Letters, 2009
- Sublingual buprenorphine/naloxone precipitated withdrawal in subjects maintained on 100mg of daily methadoneDrug and Alcohol Dependence, 2007
- Pharmacokinetic–Pharmacodynamic Modeling of the Effectiveness and Safety of Buprenorphine and Fentanyl in RatsPharmaceutical Research, 2007
- Safety and Effectiveness of Intravenous Morphine for Episodic Breakthrough Pain in Patients Receiving Transdermal BuprenorphineJournal of Pain and Symptom Management, 2006
- Buprenorphine: Considerations for Pain ManagementJournal of Pain and Symptom Management, 2005
- Altered sexual function and decreased testosterone in patients receiving intraspinal opioidsJournal of Pain and Symptom Management, 1994
- Morphine microinjections into periaqueductal grey matter of the rat: Effects on dorsal horn neuronal responses to C-fibre activity and diffuse noxious inhibitory controlsLife Sciences, 1983